These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 7036296)
1. Preliminary clinical results with norgamem (thioproline) and revercan (2-amino-2-thiazoline): the first inducers of reverse transformation. Brugarolas A; Gosálvez M Recent Results Cancer Res; 1982; 80():346-50. PubMed ID: 7036296 [No Abstract] [Full Text] [Related]
2. Thioproline (Norgamem): a useless drug in the treatment of squamous cell carcinoma. Alberto P Eur J Cancer Clin Oncol; 1981 Sep; 17(9):1061-2. PubMed ID: 7198987 [No Abstract] [Full Text] [Related]
3. Phase II trial of thioproline in advanced epidermoid head and neck tumors. Boccardo F; Barbieri A; Canobbio L; Guarneri D; Merlano M; Rosso R Cancer Treat Rep; 1982 Mar; 66(3):585-6. PubMed ID: 7060048 [No Abstract] [Full Text] [Related]
4. Treatment of cancer by an inducer of reverse transformation. Brugarolas A; Gosalvez M Lancet; 1980 Jan; 1(8159):68-70. PubMed ID: 6101417 [TBL] [Abstract][Full Text] [Related]
6. Thioproline and reversal of cancer. Gosálvez M Lancet; 1983 May; 1(8333):1108. PubMed ID: 6133140 [No Abstract] [Full Text] [Related]
7. Chemotherapy of bladder cancer: current progress. Murphy GP N Y State J Med; 1977 Oct; 77(12):1889-95. PubMed ID: 270015 [No Abstract] [Full Text] [Related]
8. Porfiromycin in the management of epidermoid and transitional cell cancer: a phase II study. Panettiere FJ; Talley RW; Torres J; Lane M Cancer Treat Rep; 1976 Jul; 60(7):907-11. PubMed ID: 795539 [TBL] [Abstract][Full Text] [Related]
9. Phase II trial of tiazofurin in recurrent squamous cell carcinoma of the head and neck. Dimery IW; Neidhart JA; McCarthy K; Krakoff IH; Hong WK Cancer Treat Rep; 1987 Apr; 71(4):425-6. PubMed ID: 3548960 [No Abstract] [Full Text] [Related]
10. [Phase II study of 5'-DFUR (Furtulon) capsule for bladder cancer]. Kubota Y; Miura T; Shuin T; Kinoshita Y; Hosaka M; Kondo I; Moriyama M; Fukushima S; Fukuoka H; Miyai K Gan To Kagaku Ryoho; 1991 Oct; 18(13):2301-6. PubMed ID: 1834023 [TBL] [Abstract][Full Text] [Related]
11. A phase II study of mitozolomide in metastatic transitional cell carcinoma of the bladder. Blackledge G; Roberts JT; Kaye S; Taylor R; Williams J; de Stavola B; Uscinska B Eur J Cancer Clin Oncol; 1989 Feb; 25(2):391-2. PubMed ID: 2702992 [No Abstract] [Full Text] [Related]
13. Segmental resection for carcinoma of the bladder: review of 102 patients. Resnick MI; O'Conor VJ J Urol; 1973 Jun; 109(6):1007-10. PubMed ID: 4710664 [No Abstract] [Full Text] [Related]
14. Phase II trial of Baker's antifol in patients with recurrent or inoperable head and neck cancer. Krasnow S; Green M; Perry DJ; Eisenberger MA; Johnston-Early A; Muggia F; Cohen MH Cancer Treat Rep; 1986 Aug; 70(8):1039-40. PubMed ID: 3524834 [No Abstract] [Full Text] [Related]
15. [Transrecters. A new group of inducers of reverse transformation with possible use in the treatment of human cancer]. Gosálvez M; Blanco MF; de Paz E Rev Esp Oncol; 1982; 29(4):821-6. PubMed ID: 6927374 [No Abstract] [Full Text] [Related]
16. Superficial bladder tumor. Aspects of clinical progression. Varkarakis MJ; Gaeta J; Moore RH; Murphy GP Urology; 1974 Oct; 4(4):414-20. PubMed ID: 4423768 [No Abstract] [Full Text] [Related]
17. Methylglyoxal bis-guanylhydrazone in advanced bladder cancer. Von Hoff DD; Blumenstein BA; Pollock TW; Crawford ED; Weick JK; Guy JT; Eisenberger M; Fletcher WS; Natale RB Eur J Cancer; 1990; 26(7):848-9. PubMed ID: 2145912 [No Abstract] [Full Text] [Related]
18. Thioproline: an inhibitor of chemical carcinogenesis. Parks RC; Jones T; Banks AR; Hessek E Neoplasma; 1982; 29(5):535-7. PubMed ID: 7177244 [TBL] [Abstract][Full Text] [Related]
19. Preliminary trials with a combination of adriamycin (NSC-123127) and bleomycin (NSC-125066) in adult malignancies. Tormey DC; Bergevin P; Blom J; Petty W Cancer Chemother Rep; 1973; 57(4):413-8. PubMed ID: 4128422 [No Abstract] [Full Text] [Related]